Investigating a new target for treating glioblastoma
SLFN5: A Novel Therapeutic Target for Glioblastoma
This study is looking at a gene called SLFN5 that seems to help glioblastoma, a tough type of brain cancer, grow faster, and the researchers want to find out how it works so they can discover new treatments that might help patients live longer and feel better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10684893 on NIH RePORTER |
What this research studies
This research focuses on glioblastoma, a highly aggressive brain cancer, by exploring a specific gene called SLFN5 that is found in higher amounts in glioblastoma cells compared to normal brain cells. The researchers aim to understand how SLFN5 contributes to tumor growth and poor patient outcomes by studying its interactions with other proteins involved in cell signaling. They will use both laboratory models and samples from patients to identify potential new therapies that could improve treatment options for glioblastoma. The goal is to find ways to inhibit SLFN5's effects, potentially leading to better survival rates for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who are seeking new treatment options.
Not a fit: Patients with other types of brain tumors or those who are not diagnosed with glioblastoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that improve survival rates for patients with glioblastoma.
How similar studies have performed: Other research has shown promise in targeting specific genes in cancer treatment, suggesting that this approach could be effective.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Platanias, Leonidas C. — Northwestern University at Chicago
- Study coordinator: Platanias, Leonidas C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.